Synthesis and pharmacological evaluation of selective MAO-A inhibitors using structure and pharmacophore-based drug design

Abstract

A combined pharmacophore and structure-based modeling method was used to study monoamine oxidase A interaction with known ligands. Pharmacophore and docking models have been worn to determine selective MAO-A inhibitors, and they agree well with docking data. In the ideal pharmacophore model, two hydrogen bonds acceptors, one hydrophobic aliphatic characteristic, and one aromatic ring characteristic are necessary. A selective MAO-A drug is identified using the structural novelty and selectivity index. UV, IR, 1H NMR, and mass spectral data were worn to characterize the Pyrimidine series of admixture. The "Porsolt behavioral despair test" on Swiss-albino mice was used to assess the antidepressant efficacy of these substances. It was found that the compounds were having comparable antidepressant activity to that of standard drug imipramine at 20 mg/kg body weight.